Literature DB >> 9472104

Cardiac autonomic dysfunction in survivors of acute lymphoblastic leukemia in childhood.

M V Kamath1, J Halton, A Harvey, S Turner-Gomes, A McArthur, R D Barr.   

Abstract

The purpose of this study was to investigate autonomic regulation of neurocardiac function in survivors of acute lymphoblastic leukemia (ALL) in childhood, through power spectral and time domain analyses of the heart rate variability signal. Studies were conducted on 34 unselected patients and 34 age matched controls. Patients were in remission, off therapy for at least 20 months and from high risk (HR, n=21) and standard risk (SR, n=13) groups as described by Dana-Farber Cancer Institute protocols 87-01 and 91-01. Twenty-nine patients had received cranial irradiation, 7 on a hyperfractionated schedule. Power spectral analysis of the heart rate (PS/HRV) was performed on 30 min heart rate time series and time domain statistics were computed from 24 h Holter recordings. Left ventricular function was assessed by measuring ejection and shortening fractions on echocardiography. All such measures were normal. Analysis of PS/HRV revealed that the supine low frequency: high frequency (LF:HF) area ratio was elevated in patients compared to controls. Changes in the LF and HF power on standing were attenuated in the patients compared to controls. Circadian analysis revealed a depressed diurnal rhythm of heart rate in the patients. Those from the SR group showed greater reduction of the LF power response to orthostatic stress and a reduced circadian rhythm of the heart rate compared to those with HR ALL. Patients from the HR group showed reductions in both HF and LF power responses to orthostasis compared to controls. Elevated supine LF power and depressed circadian variation in the HF power band were evident only in female subjects. Patients who received standard cranial irradiation had higher LF:HF area ratio and diminished LF and HF power responses to orthostatic stress than did subjects in the hyperfractionated group. These findings suggest that the autonomic nervous regulation of the heart is compromised in patients treated for ALL in childhood even when resting echocardiographic measures provide no evidence of cardiac decompensation. The extent of neurocardiac dysfunction is influenced by risk status, gender and schedule of cranial irradiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472104     DOI: 10.3892/ijo.12.3.635

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  Letter to the Editor: Re: "Is heart rate variability a valuable method to investigate cardiac autonomic dysfunction in subjects with leukemia? A systematic review to evaluate its importance in clinical practice" by Kirizawa et al.

Authors:  Maxime Caru; Daniel Curnier
Journal:  Support Care Cancer       Date:  2019-10-29       Impact factor: 3.603

2.  Cardiac autonomic dysfunction in survivors of childhood acute lymphoblastic leukemia: The St. Jude Lifetime Cohort Study.

Authors:  Lindsey Christoffersen; Todd M Gibson; Ching-Hon Pui; Vijaya Joshi; Robyn E Partin; Daniel M Green; Jennifer Q Lanctot; Carrie R Howell; Daniel A Mulrooney; Gregory T Armstrong; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  Pediatr Blood Cancer       Date:  2020-05-08       Impact factor: 3.167

3.  Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors.

Authors:  Maxime Caru; Denis Corbin; Delphine Périé; Valérie Lemay; Jacques Delfrate; Simon Drouin; Laurence Bertout; Maja Krajinovic; Caroline Laverdière; Gregor Andelfinger; Daniel Sinnett; Daniel Curnier
Journal:  Clin Res Cardiol       Date:  2019-02-18       Impact factor: 5.460

4.  Heart rate variability as a measure of autonomic dysfunction in men with advanced cancer.

Authors:  Y Guo; J L Palmer; F Strasser; S W Yusuf; E Bruera
Journal:  Eur J Cancer Care (Engl)       Date:  2013-04-30       Impact factor: 2.520

Review 5.  Cardiovascular Autonomic Dysfunction in Patients with Cancer.

Authors:  Ben G T Coumbe; John D Groarke
Journal:  Curr Cardiol Rep       Date:  2018-07-03       Impact factor: 2.931

Review 6.  Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.

Authors:  Umberto Campia; Javid J Moslehi; Laleh Amiri-Kordestani; Ana Barac; Joshua A Beckman; David D Chism; Paul Cohen; John D Groarke; Joerg Herrmann; Carolyn M Reilly; Neal L Weintraub
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

7.  Is heart rate variability a valuable method to investigate cardiac autonomic dysfunction in subjects with leukemia? A systematic review to evaluate its importance in clinical practice.

Authors:  Jociele M Kirizawa; David M Garner; Claudia Arab; Vitor E Valenti
Journal:  Support Care Cancer       Date:  2019-08-23       Impact factor: 3.603

Review 8.  Chemotherapy and Radiation-Associated Cardiac Autonomic Dysfunction.

Authors:  Alexandra E Teng; Benjamin Noor; Olujimi A Ajijola; Eric H Yang
Journal:  Curr Oncol Rep       Date:  2021-01-08       Impact factor: 5.075

9.  Physical fitness and neurocognitive outcomes in adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime cohort.

Authors:  Nicholas S Phillips; Carrie R Howell; Jennifer Q Lanctot; Robyn E Partin; Ching-Hon Pui; Melissa M Hudson; Leslie L Robison; Kevin R Krull; Kirsten K Ness
Journal:  Cancer       Date:  2019-10-21       Impact factor: 6.921

Review 10.  Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies.

Authors:  Michael A Biersmith; Matthew S Tong; Avirup Guha; Orlando P Simonetti; Daniel Addison
Journal:  J Am Heart Assoc       Date:  2020-01-21       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.